These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 9782739

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H.
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [Abstract] [Full Text] [Related]

  • 4. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I, Sanz MA.
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [Abstract] [Full Text] [Related]

  • 5. [Infectious complications in pediatric cancer patients].
    Lehrnbecher T, Laws HJ.
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S3-8. PubMed ID: 16288349
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study.
    Slobbe L, Waal Lv, Jongman LR, Lugtenburg PJ, Rijnders BJ.
    Eur J Cancer; 2009 Nov; 45(16):2810-7. PubMed ID: 19647995
    [Abstract] [Full Text] [Related]

  • 9. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
    Karthaus M, Südhoff T, Fenchel K, Egerer G, Kämpfe D, Ritter J, Franke A, Heil G, Peters G, Jürgens H.
    Wien Med Wochenschr; 1998 Nov; 148(21):481-7. PubMed ID: 10048176
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
    Girmenia C, Russo E, Carmosino I, Breccia M, Dragoni F, Latagliata R, Mecarocci S, Morano SG, Stefanizzi C, Alimena G.
    Ann Hematol; 2007 Apr; 86(4):263-70. PubMed ID: 17225113
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Febrile neutropenia in haematological malignancies.
    Sharma A, Lokeshwar N.
    J Postgrad Med; 2005 Apr; 51 Suppl 1():S42-8. PubMed ID: 16519255
    [Abstract] [Full Text] [Related]

  • 15. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments.
    Rolston KV.
    Clin Infect Dis; 2004 Jul 15; 39 Suppl 1():S44-8. PubMed ID: 15250020
    [Abstract] [Full Text] [Related]

  • 16. [Diagnostic procedures and management of Fever in pediatric cancer patients].
    Laws HJ, Ammann RA, Lehrnbecher T.
    Klin Padiatr; 2005 Nov 15; 217 Suppl 1():S9-16. PubMed ID: 16288350
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K.
    Int J Antimicrob Agents; 2005 Dec 15; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [Abstract] [Full Text] [Related]

  • 19. Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey.
    Yoshida M, Ohno R.
    Clin Infect Dis; 2004 Jul 15; 39 Suppl 1():S11-4. PubMed ID: 15250015
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.